These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33682111)

  • 21. A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.
    Huamani KF; Metch B; Broder G; Andrasik M
    Public Health Rep; 2019; 134(1):72-80. PubMed ID: 30517057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in reporting and representation by sex, race, and ethnicity in endovascular aortic device trials.
    Marcaccio CL; O'Donnell TFX; Dansey KD; Patel PB; Hughes K; Lo RC; Zettervall SL; Schermerhorn ML
    J Vasc Surg; 2022 Nov; 76(5):1244-1252.e2. PubMed ID: 35623599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minority participation in Gynecologic Oncology Group (GOG) Studies.
    Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
    Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
    Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demographic Disparities in the Federal Drug Approval Process for Allergic Rhinitis Medications.
    Liebowitz A; Spielman DB; Schlosser RJ; Stewart MG; Gudis DA
    Laryngoscope; 2023 Apr; 133(4):755-763. PubMed ID: 35394648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs: A Systematic Review.
    Onuorah HM; Charron O; Meltzer E; Montague A; Crispino A; Largent A; Lucas A; Freeman L
    Neurology; 2022 Mar; 98(9):e880-e892. PubMed ID: 35046135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
    Bibbins-Domingo K; Fernandez A
    Ann Intern Med; 2007 Jan; 146(1):52-6. PubMed ID: 17200222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Despite The FDA's Five-Year Plan, Black Patients Remain Inadequately Represented In Clinical Trials For Drugs.
    Green AK; Trivedi N; Hsu JJ; Yu NL; Bach PB; Chimonas S
    Health Aff (Millwood); 2022 Mar; 41(3):368-374. PubMed ID: 35254926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial and Ethnic Distribution in Diabetic Macular Edema Clinical Trials in the United States (2002-2021).
    Yu AJ; Masalkhi M; Brown R; Chen B; Chhablani J
    Ophthalmol Retina; 2023 Dec; 7(12):1035-1041. PubMed ID: 37479084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials.
    Kanapuru B; Fernandes LL; Fashoyin-Aje LA; Baines AC; Bhatnagar V; Ershler R; Gwise T; Kluetz P; Pazdur R; Pulte E; Shen YL; Gormley N
    Blood Adv; 2022 Mar; 6(6):1684-1691. PubMed ID: 35114691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug Approvals.
    Idris MY; Fitzsimmons WE; Pemu P
    Ther Innov Regul Sci; 2024 Jan; 58(1):175-183. PubMed ID: 37872439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies.
    Mendis S; Anand S; Karasinska JM; Dasari A; Unger JM; Gothwal A; Ellis LM; Varadhachary G; Kopetz S; Overman MJ; Raghav K; Loree JM
    Oncologist; 2021 Feb; 26(2):107-114. PubMed ID: 32960478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs.
    Miller JE; Mello MM; Wallach JD; Gudbranson EM; Bohlig B; Ross JS; Gross CP; Bach PB
    JAMA Netw Open; 2021 May; 4(5):e217075. PubMed ID: 33950209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities in US Lung Cancer Clinical Trial Enrollment.
    Kilic S; Zhao J; Okut H; Jani CT; Radwan A; Dudipala H; Burns L; Tapan U
    J Racial Ethn Health Disparities; 2023 Aug; ():. PubMed ID: 37651069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics.
    Varma T; Wallach JD; Miller JE; Schnabel D; Skydel JJ; Zhang AD; Dinan MA; Ross JS; Gross CP
    JAMA Netw Open; 2021 Apr; 4(4):e217063. PubMed ID: 33877309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020.
    Lythgoe MP; Krell J; Savage P; Prasad V
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1208-1211. PubMed ID: 33859363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underrepresentation of black individuals in pivotal trials for novel anticancer drugs: Potential consequence of using estimated creatinine clearance to assess kidney function?
    Butrovich MA; Reaves AC; Heyward J; Moore TJ; Alexander GC; Inker LA; Nolin TD
    Contemp Clin Trials; 2024 Sep; 144():107631. PubMed ID: 39019154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
    Lolic M; Araojo R; Okeke M; Temple R
    J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020.
    Chiang RS; Desai A; Glover MJ; Hui G; Ramchandran KJ; Wakelee H; Lythgoe MP; Khaki AR
    Cancer Invest; 2023 Jan; 41(1):43-47. PubMed ID: 36197034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial disparities in Black men with prostate cancer: A literature review.
    Lillard JW; Moses KA; Mahal BA; George DJ
    Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.